From neoadjuvant to organ-sparing immunotherapy for colorectal cancer Nature.com Nawigacja wpisu A promising new class of medicines gathers pace – The Economist Vertex, U.K. reach deal to provide CRISPR-based medicine to thalassemia patients in England – STAT
